Home›Stock Screener›SHARMEH

SHARMEH Share Price Today | Stock Price & SHARMEH Share Screener

SHARMEH Healthcare Services
Live Share Price BSE
₹79.04
▼ -4.95 (-5.89%)
2026-11-19 00:00:00

As of November 19, 2026, the live SHARMEH share price (BSE: SHARMEH) is ₹79.04, down 5.89% from the previous close, with shares trading between ₹79.00 and ₹81.70 in today's trading session, and a 52-week range of ₹78.00–₹141.75. Track SHARMEH market cap trends to gauge the company's total market size. Use the SHARMEH stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today SHARMEH opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹38 and net income of ₹1, with EBITDA of ₹4, an operating margin of 10.0% and a profit margin of 2.6%.

SHARMEH Market Cap ₹26.30 Cr.
SHARMEH P/E Ratio (TTM) 23.30
SHARMEH P/B Ratio 1.97
EPS (TTM) ₹3.78
Dividend Yield -
Debt to Equity 0.36
SHARMEH 52 Week High ₹141.75
SHARMEH 52 Week Low ₹78.00
Operating Margin 10.00%
Profit Margin 2.63%
SHARMEH Revenue (TTM) ₹38.00
EBITDA ₹4.00
Net Income ₹1.00
Total Assets ₹33.00
Total Equity ₹14.00

SHARMEH Share Price Chart

Track the current stock price of SHARMEH with an interactive chart. Analyse SHARMEH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete SHARMEH stock quote in one place.

The quote of ₹79.04 sits between the 52-week low of ₹78.00 and the 52-week high of ₹141.75, and the latest session moved -5.89% from the previous close.

SHARMEH Company Profile - Fundamental Screener

Screen SHARMEH company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SHARMEH shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE465H01012.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE465H01012

SHARMEH Balance Sheet Screener

Screen SHARMEH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹33, up from ₹28 in 2025.

Latest statistics put total assets at ₹33 and shareholder funds at ₹14, with a leverage ratio of 0.36.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 33 28 25 24 19 19 20 22 16 18
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 8 9 8 9 7 6 4 5 6 6

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 1 2 2 2 2 1 2 2
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 14 13 11 11 10 9 8 8 8 8
Share Capital 4 4 4 4 4 4 4 4 4 4
Reserves & Surplus 10 8 7 6 5 5 4 4 4 3

SHARMEH Income Statement Screener - Profit & Revenue Analysis

Screen SHARMEH income statement and profit fundamentals. Analyze SHARMEH quarterly results. SHARMEH reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹38 and net profit was ₹1, equal to earnings per unit of ₹3.40, at an operating margin of 10%.

In that period expenses were ₹35, interest cost ₹1 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹36 and net profit of ₹1.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 38 36 30 24 21 17 11 16 16 16 17 17 17
Expenses 35 32 26 20 17 15 9 14 14 15 16 16 15

Operating Costs and Margins

EBITDA 4 4 4 3 3 2 2 2 2 2 2 1 2
Operating Profit % 10.00% 10.00% 12.00% -10.00% 16.00% 13.00% -8.00% 12.00% 4.00% 9.00% 10.00% 5.00% 8.00%
Depreciation 2 2 2 2 1 1 1 0 1 1 1 1 1
Interest 1 1 1 1 1 1 1 1 1 1 1 1 1

Profit and Earnings

Profit Before Tax 1 2 1 1 1 1 1 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 1 1 1 1 1 0 0 0 0 0 1
EPS 3.40 3.78 3.79 2.02 2.96 2.07 1.94 1.18 0.81 0.40 0.26 0.09 1.74

SHARMEH Cash Flow Screener - Liquidity Fundamentals

Screen SHARMEH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹4.

Over the same period, investing activities used ₹1 and financing activities provided ₹5.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -4 7 -1 1 2 1 1 -1 3 1
Investing Activities -1 -3 5 -4 -2 3 -2 2 0 -1

Financing and Net Cash

Financing Activities 5 -4 -4 3 -2 -2 -5 5 -3 0
Net Cash Flow 0 0 0 0 -2 2 -5 5 0 0

SHARMEH Shareholding Pattern Screener

See SHARMEH shareholding pattern with promoter, FII, and DII holdings. Check SHARMEH promoter holding and ownership changes for SHARMEH on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 53.63%, foreign institutions 0.00%, domestic institutions 0.00% and the public 33.33%, spread across 4,210 shareholders.

The shareholder count was 4,210 in 2026-Mar, compared with 4,211 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 53.63% 53.63% 53.63% 53.63% 53.63% 53.63% 53.63% 53.63%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 33.33% 33.33% 32.30% 33.50% 33.50% 33.49% 33.31% 32.83%
Other Holding 13.03% 13.03% 14.07% 12.86% 12.86% 12.88% 13.06% 13.53%
Shareholder Count 4,210 4,211 4,199 4,068 4,147 4,377 4,226 3,698

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by SHARMEH. SHARMEH dividend yield can be compared with peers and other stocks in the market.

No dividends declared by SHARMEH.

SHARMEH Stock Index Membership - Nifty & Sensex

See which indices include SHARMEH stock. Check SHARMEH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

SHARMEH is not part of any tracked indices.
Only major market indices are tracked in our system.

SHARMEH Market Events Screener - Corporate Actions

Get SHARMEH corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check SHARMEH stock events that may affect SHARMEH share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 7, 2026, with a record date of November 7, 2026.

It is followed by Annual General Meeting dated September 30, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-07 2026-11-07 Quarterly Result Announcement NA 6.11%
2026-09-30 2026-09-30 Annual General Meeting NA -9.30%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -3.65%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 7.74%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 15.01%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -3.69%
2025-09-30 2025-09-30 Annual General Meeting NA -19.83%
2025-08-08 2025-08-08 Quarterly Result Announcement NA -4.46%
2025-05-23 2025-05-23 Quarterly Result Announcement NA -1.35%
2025-01-10 2025-01-10 Quarterly Result Announcement NA 10.38%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.86%
2024-09-30 2024-09-30 Annual General Meeting NA -16.46%

SHARMEH Competitors Screener - Peer Stocks Comparison

Screen SHARMEH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 122,591 52.40 25,420 15.58% 2,003 57.80
Max Healthcare Institute 92,182 66.60 8,536 18.82% 1,442 62.55
Manipal Health Enterprises 89,630 98.20 10,521 25.80% 917 55.29
Aster DM Quality Care 62,978 113.80 4,769 11.25% 427 54.92
Fortis Healthcare 57,679 54.00 9,179 16.93% 1,064 46.04
Global Health 39,094 63.10 4,509 19.56% 554 68.03
Narayana Hrudayalaya 38,019 43.70 7,996 43.43% 811 56.24
Dr. Lal Path Labs 33,452 57.30 2,864 12.11% 510 56.83
Krishna Institute of Medical Sciences 30,646 155.10 3,931 28.16% 242 54.48
Syngene International 17,935 97.10 3,809 2.56% 317 68.00

SHARMEH Company Announcements - News & Reports Screener

Screen SHARMEH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 12, 2026.

The next most recent announcements are dated November 12, 2026 and November 3, 2026.

Date Update Actions
2026-11-12 Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2026 -
2026-11-12 Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Unaudited Fianncial Results For The Quarter And Half Year Ended 30-09-2026 -
2026-11-03 Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2026 -
2026-10-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-29 Closure of Trading Window -
2026-09-08 Reg. 34 (1) Annual Report. -
2026-09-08 Notice Of 37Th Annual General Meeting Schedule To Be Held On 30Th September 2026 -
2026-09-08 Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday September 08 2026 -
2026-08-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-12 Approval Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015 -
2026-08-12 Board Meeting Outcome for Approval Of Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015 -
2026-08-04 Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. -
2026-07-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-22 Closure of Trading Window -
2026-06-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-31 Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 -
2026-05-30 Board Meeting Outcome for Outcome Of Board Meeting Held On May 30 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations. 2015. -
2026-05-15 Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹79.04, within a 52-week range of ₹78.00 to ₹141.75. The P/E ratio is 23.30 and the P/B ratio is 1.97, with earnings per unit of ₹3.78. Market capitalisation stands at ₹26.30 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.